[1]郭玮平,王 杰,管一伟,等.肝动脉化疗栓塞联合微波消融与外科根治性切除治疗小肝癌的对照研究[J].介入放射学杂志,2019,28(07):642-646.
 GUO Weiping,WANG Jie,GUAN Yiwei,et al.TACE combined with microwave ablation versus radical surgical resection for the treatment of small HCC: a comparison study[J].journal interventional radiology,2019,28(07):642-646.
点击复制

肝动脉化疗栓塞联合微波消融与外科根治性切除治疗小肝癌的对照研究()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
28
期数:
2019年07期
页码:
642-646
栏目:
肿瘤介入
出版日期:
2019-07-25

文章信息/Info

Title:
TACE combined with microwave ablation versus radical surgical resection for the treatment of small HCC: a comparison study
作者:
郭玮平 王 杰 管一伟 张金星 祖庆泉 施海彬
Author(s):
GUO Weiping WANG Jie GUAN Yiwei ZHANG Jinxing ZU Qingquan SHI Haibin.
Department of Interventional Radiology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province 210029, China
关键词:
【关键词】 小肝癌 肝动脉化疗栓塞 微波消融 外科切除
文献标志码:
A
摘要:
【摘要】 目的 比较TACE联合微波消融(TACE- MWA)与外科根治性切除(SR)治疗小肝癌的临床疗效。 方法 回顾性分析2010年1月至2017年12月行TACE- MWA或SR治疗的199例小肝癌患者的临床资料。TACE- MWA与SR治疗的患者按1 ∶ 2行倾向性匹配,分析两组术后的无疾病生存率(DFS)和总生存率(OS)。 结果 匹配后共纳入患者72例(TACE- MWA组24例,SR组48例)。所有患者平均随访时间29.2个月(TACE- MWA:26.1个月;SR:30.8个月)。TACE- MWA组和SR组的1、2和3年的DFS分别为78.8%、78.8%、56.2%和91.7%、71.9%、62.5%。TACE- MWA组和SR组的1、2和3年的OS分别为100%、95.5%、95.5%和100%、97.5%、97.5%。两组间的DFS和OS差异均无明显统计学意义(P=0.730和P=0.648)。 结论 与SR相比,TACE- MWA治疗小肝癌的DFS与OS差异均无明显统计学意义。TACE- MWA可以成为治疗小肝癌的一种有效模式。

参考文献/References:

[1] Berretta M, Cavaliere C, Alessandrini L, et al. Serum and tissue marks in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications[J]. Oncotarget, 2017, 8: 14192- 14220.
[2] Forner A, Reig ME, de Lope CR, et al. Current strategy for staging and treatment: the BCLC update and future prospects[J]. Semin Liver Dis, 2010, 30: 61- 74.
[3] Ye SL, Takayama T, Geschwind J, et al. Current approaches to the treatment of early hepatocellular carcinoma[J]. Oncologist, 2010, 15: 34- 41.
[4] 李 征, 米登海, 杨克虎, 等. 经动脉化疗栓塞联合微波消融治疗肝癌有效性和安全性的系统评价[J]. 介入放射学杂志, 2015, 24: 957- 963.
[5] Terzi E, Piscaglia F, Forlani L, et al. TACE performed in patients with a single nodule of hepatocellular carcinoma[J]. BMC Cancer, 2014, 14: 601.
[6] Song MJ, Bae SH, Lee JS, et al. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma[J]. Korean J Intern Med, 2016, 31: 242- 252.
[7] Feng K, Yan J, Li X, et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma[J]. J Hepatol, 2012, 57: 794- 802.
[8] Donadon M, Solbiati L, Dawson L, et al. Hepatocellular carcinoma: the role of interventional oncology[J]. Liver Cancer, 2017, 6: 34- 43.
[9] Chinnaratha MA, Chuang MY, Fraser RJ, et al. Percutaneous thermal ablation for primary hepatocellular carcinoma: a systematic review and meta- analysis[J]. J Gastroenterol Hepatol, 2016, 31: 294- 301.
[10] 宗迎迎, 徐 浩, 许 伟, 等. 经肝动脉化疗栓塞联合经皮微波消融序贯治疗早期肝癌的疗效及预后影响因素[J]. 介入放射学杂志, 2015, 24: 210- 214.
[11] Seki T, Tamai T, Nakagawa T, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma[J]. Cancer, 2000, 89: 1245- 1251.
[12] 杨维竹, 江 娜, 黄 宁, 等. 经导管肝动脉化疗栓塞联合经皮微波凝固治疗小肝癌[J]. 中国医学影像技术, 2008, 24: 1647- 1649.
[13] Wang WD, Hou SN, Zhong ZL, et al. Radiofrequency ablation combined with transcatheter arterial chemoembolization therapy versus surgical resection for Barcelona- Clinic Liver Cancer(BCLC)A hepatocellular carcinoma: a meta- analysis[J]. J Intervent Med, 2018, 1: 49- 57.
[14] Chen QF, Jia ZY, Yang ZQ, et al. Transarterial chemoembolization monotherapy versus combined transarterial chemoembolization- microwave ablation therapy for hepatocellular carcinoma tumors ≤5 cm: a propensity analysis at a single center[J]. Cardiovasc Intervent Radiol, 2017, 40: 1748- 1755.
[15] Shi J, Sun Q, Wang Y, et al. Comparison of microwave ablation and surgical resection for treatment of hepatocellular carcinomas conforming to Milan criteria[J]. J Gastroenterol Hepatol, 2014, 29: 1500- 1507.

相似文献/References:

[1]程洁敏,王建华.喜树碱微球化疗栓塞治疗原发性肝癌10例报告[J].介入放射学杂志,1993,(01):47.
[2]卢丽琴,陈方宏,袁建华,等.晚期肝癌伴门脉癌栓的介入治疗[J].介入放射学杂志,1996,(03):136.
[3]姚红响,陈根生,诸葛英,等.肝动脉化疗栓塞联合CT引导射频消融序贯治疗中小肝癌的临床应用[J].介入放射学杂志,2012,(04):301.
 ,,et al.Sequential treatment with TACE and CTguided RFA for small and moderate sized HCC [J].journal interventional radiology,2012,(07):301.
[4]帕哈尔丁·白克热,杨树法,黄伍奎,等.肝动脉化疗栓塞联合射频消融术治疗30例原发性大肝癌的疗效评价[J].介入放射学杂志,2012,(04):322.
 ,,et al.TACE combined with radiofrequency ablation for massive primary hepatocellular carcinomas: a clinical therapeutic evaluation [J].journal interventional radiology,2012,(07):322.
[5]杨永波,程红岩.肝动脉化疗栓塞治疗中碘油用量的现状与研究进展[J].介入放射学杂志,2012,(04):348.
 .The volume of Lipiodol used in TACE: its current situation and research progress [J].journal interventional radiology,2012,(07):348.
[6]赵许亚,周 石.TACE联合经皮瘤内注射碘油吡柔比星乳剂治疗中晚期肝癌疗效分析[J].介入放射学杂志,2012,(08):675.
 ZHAO Xu- ya,ZHOU Shi.. Transcatheter artery chemoembolization combined with percutaneous intratumoral injection of Lipiodol emulsion of pirarubicin for advanced hepatocellular carcinomas: an analysis of clinical efficacy[J].journal interventional radiology,2012,(07):675.
[7]施振静,虞希祥,郝伟远,等.C臂CT在肝癌TACE术中评估碘油沉积的应用价值[J].介入放射学杂志,2013,(04):301.
 SHI Zhen? jing,YU Xi? xiang,HAO Wei? yuan,et al.Clinical value of DynaCT scanning in assessing iodized oil deposition degree within the tumor during transcatheter arterial chemoembolization for hepatocellular carcinoma[J].journal interventional radiology,2013,(07):301.
[8]沈 杰,于学涛,范晓强,等. TACE和微波凝固术联合重组人血管内皮抑素治疗大肝癌25例的临床研究[J].介入放射学杂志,2013,(12):995.
 SHEN Jie,YU Xue? tao,FAN Xiao? qiang,et al.TACE and microwave coagulation combined with recombinant human endostatin for the treatment of large liver cancer: a clinical study in 25 cases[J].journal interventional radiology,2013,(07):995.
[9]丁以锟,吕维富,周春泽,等. 术后预防性肝动脉化疗栓塞对肝癌患者生存的影响及预后相关因素分析[J].介入放射学杂志,2014,(04):299.
 DING Yi-kun,LV Wei-fu,ZHOU Chun-ze,et al. The influence of postoperative TACE on the survival time and prognosis in hepatocellular carcinoma patients after liver resection[J].journal interventional radiology,2014,(07):299.
[10]纪岩磊,韩 真,邵丽梅,等.经肝动脉化疗栓塞术、经门静脉化疗栓塞术联合高强度聚焦超声治疗门静脉癌栓的临床研究[J].介入放射学杂志,2015,(03):256.
 JI Yan lei,HAN Zhen,SHAO Li mei,et al.Combination use of TACE, PVE and HIFU for the treatment of portal vein cancerous thrombus: a clinical study[J].journal interventional radiology,2015,(07):256.

备注/Memo

备注/Memo:
(收稿日期:2019-01-17)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2019-07-16